Comment: Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy

Comment: Kidney surgery may be unneeded in many intermediate-risk patients

Genetic testing of early breast tumours could allow patients to go without chemo

PD-1 immunotherapy better than chemo alone as first line lung cancer treatment

Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy

Kidney surgery may be unneeded in many intermediate-risk patients

Cancer treatment in the last 6 months of life: when inaction can outperform action

A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers

Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer

Improving global breast cancer care

What will we expect from novel therapies for oesophageal and gastric malignancies?

Nelarabine in newly diagnosed paediatric T-cell malignancies